<SEC-DOCUMENT>0001104659-24-084997-index.html : 20240920
<SEC-HEADER>0001104659-24-084997.hdr.sgml : 20240920
<ACCEPTANCE-DATETIME>20240801175758
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-24-084997
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20240802
<PUBLIC-REL-DATE>20240920
DATE AS OF CHANGE:		20240801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Camp4 Therapeutics Corp
		CENTRAL INDEX KEY:			0001736730
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-07276
		FILM NUMBER:		241168164

	BUSINESS ADDRESS:	
		STREET 1:		ONE KENDALL SQUARE
		STREET 2:		BUILDING 1400 WEST, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-651-8867

	MAIL ADDRESS:	
		STREET 1:		ONE KENDALL SQUARE
		STREET 2:		BUILDING 1400 WEST, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
Document 1 - file: filename1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_camp4-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_camp4-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ph_identify-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: ph_identify-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fc_ourpipeline-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: fc_ourpipeline-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ph_geneexpression-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: ph_geneexpression-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bc_functionaldisorder-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: bc_functionaldisorder-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ph_sodiumacetate-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: ph_sodiumacetate-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>pc_ucdpatient-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: pc_ucdpatient-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>bc_concentration-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: bc_concentration-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lc_ureaproduction-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: lc_ureaproduction-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>lc_ammonialevel-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: lc_ammonialevel-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>lc_ammoniaureagen-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: lc_ammoniaureagen-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>bc_ucdmrna-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 13 - file: bc_ucdmrna-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>lc_ureagenesisauc-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 14 - file: lc_ureagenesisauc-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>fc_clinicaltrialdesign-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 15 - file: fc_clinicaltrialdesign-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>bc_ldlrincrease-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 16 - file: bc_ldlrincrease-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>bc_ldlrreductions-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 17 - file: bc_ldlrreductions-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>lc_syngap1brainsofmice-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 18 - file: lc_syngap1brainsofmice-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>lc_humanneurons-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 19 - file: lc_humanneurons-4c.jpg

</DOCUMENT>
</SEC-DOCUMENT>